Health insurance promises peace of mind. But in an era of predictable disease, does it still protect health, or merely pay for its loss?

Most insurance policies only pay out once an illness or injury has occurred, covering hospitalisation and treatment costs. Care that could have prevented a condition from worsening is often treated as secondary rather than core.

While preventive features increasingly exist, neither product, in its traditional structure, is designed with prevention as the primary driver of value.

Across Asia, where chronic diseases now account for more than 70 percent of deaths and healthcare costs¹ continue to rise faster than income, this model increasingly diverges from today’s disease patterns. The question is no longer how much protection we can afford, but what kind of protection truly sustains health.

The legacy of a reactive system

Health insurance was built for a world of unpredictable, high-cost events like accidents or infections. Its role was clear: protect families from financial catastrophe.

That logic made sense when illness struck suddenly. Today, however, the region’s leading drivers of disease burden, including diabetes, hypertension, and cardiovascular disease, develop gradually over the years and are largely preventable.

Despite this shift, most systems continue to reimburse treatment after illness occurs rather than reducing risk earlier, much like fire insurance that pays for damage but doesn’t support measures that prevent the fire in the first place.

When prevention feels like a risk

Even where preventive screenings are available, many people delay or avoid them, not out of apathy, but hesitation.

Insurance reduces fear of financial loss. Yet when coverage is triggered primarily after diagnosis, it can unintentionally discourage early engagement with care. This isn’t emotional fear. It’s rational risk anticipation shaped by how coverage and underwriting have historically functioned.

Policyholders often associate diagnosis with downstream consequences, even as insurers expand screening benefits. Availability doesn’t always translate into uptake.

The issue isn’t whether screenings exist. It’s whether prevention truly matters in how premiums are set, care is reimbursed and outcomes are judged.

Where health literacy fits in

Prevention also depends on health literacy.

Screenings and outpatient benefits assume that people know when to seek care, how to interpret results, and where to go next. In practice, many don’t. Early warning signs are missed. Follow-up is delayed. Care is often sought only when symptoms become disruptive.

Low health literacy doesn’t reflect indifference. It reflects systems that shift navigation responsibility to individuals, while rewarding care only once illness has advanced.

Prevention, therefore isn’t only about access. It’s about enabling people to recognise risk early, navigate care appropriately, and act before illness escalates into crisis.

Related: Why prevention is the new cure: Rethinking how we approach health

Coverage without prevention is still a costly reaction

Even with outpatient benefits, most insurance remains fundamentally reactive. It pays for what has already happened, reinforcing a cycle of delayed care and treatment.

Across Asia, medical costs continue to outpace wage growth and general inflation, driven by ageing populations and hospital-centred care models. The greatest mismatch lies not in catastrophic care, but in the day-to-day management of health.

For many people living with chronic conditions, the real burden isn’t a single hospital bill. It’s the accumulation of routine care: primary care consultations, monitoring tests, and long-term medications taken over years. These services keep conditions stable and complications at bay, yet they’re often only partially covered or not claimable at all.

As a result, individuals shoulder ongoing out-of-pocket costs for managing diabetes, hypertension, or high cholesterol, even though these conditions drive the bulk of long-term healthcare demand.

Such conditions rarely require acute or episodic intervention. They require consistency, including medication adherence, follow-up visits, and ongoing monitoring. This is where health is preserved, and where traditional insurance provides the least reinforcement.

This design also creates system strain. When hospitalisation becomes the primary gateway to reimbursement, patients may seek admission even for manageable conditions, not because it’s clinically necessary, but because it unlocks coverage. Beds are then occupied by cases that could have been managed in primary care, limiting capacity for more complex needs.

As medical costs rise, premiums inevitably follow. Individuals and employers face annual premium increases driven by hospital utilisation, chronic disease burden and medical inflation. Insurance remains essential, yet increasingly expensive, reinforcing affordability concerns even among the insured.

When care is financed mainly after illness occurs, rising utilisation translates directly into higher premiums, regardless of individual health behaviour.

Prevention may not always save money immediately, but it consistently reduces downstream risk. Many cases of blood pressure controlled early reduce the likelihood of hospitalisation later.